Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Cardiology

The Heart’s Electrical and Structural Changes

At a Glance

Atrial fibrillation is more than an irregular heartbeat: scarring, altered electrical signaling, and enlargement of the atria can help the rhythm persist. Symptoms may be subtle or absent, so stroke risk and treatment decisions rely on clinical factors, not symptoms alone.

Receiving a diagnosis of Atrial Fibrillation (AFib) can feel like your heart has developed a mind of its own. It is natural to feel anxious or overwhelmed when told your heart rhythm is “irregular” or “chaotic.” However, understanding that AFib is more than just a fast heartbeat—it is a complex disease of the heart’s upper chambers—can help you take control of your care.

More Than a Rhythm: Atrial Myopathy

While AFib is often described as an electrical problem, modern medicine increasingly views it as part of a broader, evolving research concept called atrial myopathy (or atrial cardiomyopathy) [1]. This means the tissue of the atria (the heart’s two upper chambers) has undergone physical and biological changes that make it harder for electricity to flow smoothly [2].

Think of your heart’s electrical system like a series of paved roads. In a healthy heart, electrical signals travel along these roads in a predictable, synchronized way. In atrial myopathy, the “roads” themselves are damaged by:

  • Fibrosis: The development of scar-like tissue that replaces healthy muscle [3]. This scar tissue acts like a roadblock or a detour, forcing electrical signals to wander and spin in circles [4]. Note: Atrial myopathy and fibrosis are evolving research concepts and not routinely measured directly in standard care, though echocardiograms can estimate indirect markers like atrial enlargement.
  • Electrical Remodeling: Changes at the cellular level, such as how the heart moves calcium and potassium, which shorten the heart’s “reset” time and make it easier for “short circuits” to occur [5][6].
  • Structural Stretching: Over time, the atria can become dilated (enlarged), which further disrupts the electrical signals and creates more space for chaotic rhythms to persist [7].

The Biological “Soil”: Inflammation and Stress

Your heart doesn’t change overnight. Several underlying biological pathways, currently under active study, act like “fertilizer” for the disease, helping AFib take root and grow.

  • Inflammation: Systemic inflammation from other health conditions can irritate the heart tissue, contributing to the growth of fibrosis and disrupting the heart’s natural rhythm [8].
  • Oxidative Stress: This occurs when there is an imbalance of certain molecules (reactive oxygen species) in your cells. This stress can damage the heart’s power plants (mitochondria) and lead to the cellular changes that keep AFib going [9].
    Rather than seeking unproven anti-inflammatory or antioxidant treatments, focus on evidence-based management of blood pressure, weight, and sleep apnea.

The “Silent” Nature of AFib

One of the most confusing aspects of AFib is that you may not feel it at all. This is known as asymptomatic or “silent” AFib.

  • Prevalence: Approximately 25% to 33% of people newly diagnosed with AFib report having no symptoms [10][11].
  • Why it’s silent: Your body may simply adapt to the irregular rhythm, or the “episodes” may be too short for you to notice. However, even if you cannot feel the AFib, the underlying atrial myopathy can still progress. The absence of symptoms does not make your stroke risk zero, as stroke risk is determined by your clinical risk factors rather than by whether you feel an episode [1][12].

Recognizing Common and Overlooked Symptoms

While many focus on “racing” or “thumping” in the chest, AFib symptoms can be much more subtle. Because the atria are not pumping efficiently, your heart has to work harder to move blood, which can lead to:

  • Fatigue: A general, heavy sense of exhaustion that isn’t solved by sleep [13].
  • Shortness of Breath (Dyspnea): Feeling winded during activities that were previously easy, such as walking up a flight of stairs or gardening [14].
  • Exercise Intolerance: A noticeable drop in your physical stamina or “gas in the tank” during a workout [14].
  • Lightheadedness or Dizziness: Feeling faint or unsteady, often when an episode begins or ends [13].
  • Vague “Low Energy”: Many patients only realize how much energy they had lost after their rhythm is restored to normal [14].

Understanding that these “vague” feelings can be signals from your heart is the first step in managing the condition. (Note: While these symptoms may be related to your AFib, they are non-specific. Your clinician may also evaluate you for medication side effects, anemia, thyroid disease, or sleep apnea to ensure no other causes exist). By viewing AFib as a disease of the heart tissue itself—not just a temporary glitch—you and your care team can focus on treating both the rhythm and the underlying conditions that contribute to it.

Common questions in this guide

What does atrial myopathy mean in atrial fibrillation?
Atrial myopathy means that the heart’s upper chambers have developed physical or biological changes that make normal electrical signaling harder. These changes can include scar-like tissue, altered cell behavior, and enlargement of the atria. It is an evolving research concept and is not routinely measured directly in standard care.
Can I have AFib without feeling any symptoms?
Yes. About 25% to 33% of people newly diagnosed with AFib report no symptoms, either because the body adapts or episodes are brief. Silent AFib can still be associated with stroke risk, which is assessed from clinical risk factors rather than symptoms alone.
What symptoms can atrial fibrillation cause besides a racing heartbeat?
AFib can cause fatigue, shortness of breath, reduced exercise stamina, lightheadedness, dizziness, or a vague loss of energy. Some people notice fluttering or thumping, while others notice only a decline in daily activities. These symptoms can have other causes, so a clinician may also check for medication effects, anemia, thyroid disease, or sleep apnea.
Do atrial enlargement or fibrosis change AFib treatment?
They may influence how your clinician evaluates AFib and discusses options such as rhythm treatment or ablation. A larger or more remodeled atrium can be relevant to how persistent the rhythm is and the expected benefit of a procedure, but your overall plan also depends on symptoms, other health conditions, and stroke risk. Echocardiograms can estimate indirect signs such as atrial enlargement, while fibrosis is not routinely measured directly in standard care.
Which health conditions can contribute to changes in the atria?
High blood pressure, excess weight, and sleep apnea can contribute to changes in the heart’s structure and make AFib harder to control. Inflammation from other health conditions may also contribute to tissue changes. Managing these factors with evidence-based care is part of AFib treatment.
How is AFib monitored if I do not notice symptoms?
When symptoms are absent or unreliable, your care team can use follow-up visits and heart-rhythm testing or monitoring to assess whether AFib is present and how it is behaving. The approach depends on your episode pattern and treatment. Feeling well does not by itself mean that AFib or stroke risk has gone away.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my testing, do I have signs of atrial myopathy, such as atrial enlargement or fibrosis?
  2. 2.What is the likely cause of my AFib—is it primarily electrical, or is there significant structural remodeling?
  3. 3.Since I don't always feel symptoms, how will we monitor whether my AFib is well-controlled?
  4. 4.Does the amount of fibrosis or the size of my left atrium change my treatment plan or the likelihood of success with procedures like ablation?
  5. 5.Are my symptoms of fatigue and low energy likely related to AFib, even if I don't feel palpitations?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Pathophysiology and clinical relevance of atrial myopathy.

    Tubeeckx MRL, De Keulenaer GW, Heidbuchel H, Segers VFM

    Basic research in cardiology 2024; (119(2)):215-242 doi:10.1007/s00395-024-01038-0.

    PMID: 38472506
  2. 2

    Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).

    Goette A, Corradi D, Dobrev D, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2024; (26(9)) doi:10.1093/europace/euae204.

    PMID: 39077825
  3. 3

    Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications.

    Horrach CV, Bevis L, Nwanna C, et al.

    The Journal of physiology 2026; (604(13)):5103-5125 doi:10.1113/JP288680.

    PMID: 40434291
  4. 4

    Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards.

    Quah JX, Dharmaprani D, Tiver K, et al.

    Journal of cardiovascular electrophysiology 2021; (32(4)):1147-1160 doi:10.1111/jce.14987.

    PMID: 33682258
  5. 5

    Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.

    Zhao H, Li T, Liu G, et al.

    Journal of cardiovascular pharmacology and therapeutics 2019; (24(6)):575-585 doi:10.1177/1074248419854749.

    PMID: 31159577
  6. 6

    Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

    Denham NC, Pearman CM, Caldwell JL, et al.

    Frontiers in physiology 2018; (9()):1380 doi:10.3389/fphys.2018.01380.

    PMID: 30337881
  7. 7

    Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?

    Lorenzo-Almorós A, Casado Cerrada J, Álvarez-Sala Walther LA, et al.

    Journal of clinical medicine 2023; (12(8)) doi:10.3390/jcm12082868.

    PMID: 37109205
  8. 8

    Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets.

    Lu YY, Chen YJ, Lip GYH, Chen SA

    European heart journal 2026; (47(23)):2894-2912 doi:10.1093/eurheartj/ehag131.

    PMID: 41879137
  9. 9

    Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.

    Gutierrez A, Van Wagoner DR

    Journal of cardiovascular pharmacology 2015; (66(6)):523-9 doi:10.1097/FJC.0000000000000313.

    PMID: 26335221
  10. 10

    Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis.

    Pamporis K, Karakasis P, Sagris M, et al.

    European journal of preventive cardiology 2025; doi:10.1093/eurjpc/zwaf138.

    PMID: 40053837
  11. 11

    Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke-Insights From the GLORIA-AF Registry (Phase 2).

    Heer T, Zeymer U, Schwarzbach CJ, et al.

    Pacing and clinical electrophysiology : PACE 2025; (48(1)):42-49 doi:10.1111/pace.15113.

    PMID: 39603823
  12. 12

    Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.

    Schnabel RB, Haeusler KG, Healey JS, et al.

    Circulation 2019; (140(22)):1834-1850 doi:10.1161/CIRCULATIONAHA.119.040267.

    PMID: 31765261
  13. 13

    Perception of atrial fibrillation symptoms: Impact on quality of life and treatment in older adults.

    Abu HO, Wang W, Otabil EM, et al.

    Journal of the American Geriatrics Society 2022; (70(10)):2805-2817 doi:10.1111/jgs.17954.

    PMID: 35791806
  14. 14

    Exercise capacity and quality-of-life improvements after catheter ablation in patients with clinically asymptomatic persistent atrial fibrillation.

    Fujisawa T, Kawakami H, Kurokawa K, et al.

    Heart rhythm 2026; (23(7)):e1000-e1011 doi:10.1016/j.hrthm.2026.03.1947.

    PMID: 41933635

This page is for informational purposes only and does not constitute medical advice. Ask your cardiology team to interpret your tests, symptoms, and stroke risk and guide your care.

Get notified when new evidence is published on atrial fibrillation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.